AU2019220368B2 - Modified viral capsids - Google Patents

Modified viral capsids Download PDF

Info

Publication number
AU2019220368B2
AU2019220368B2 AU2019220368A AU2019220368A AU2019220368B2 AU 2019220368 B2 AU2019220368 B2 AU 2019220368B2 AU 2019220368 A AU2019220368 A AU 2019220368A AU 2019220368 A AU2019220368 A AU 2019220368A AU 2019220368 B2 AU2019220368 B2 AU 2019220368B2
Authority
AU
Australia
Prior art keywords
seq
pro
modified
ser
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019220368A
Other languages
English (en)
Other versions
AU2019220368A1 (en
Inventor
Tomas BJÖRKLUND
Marcus Davidsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brave Bioscience AB
Original Assignee
Brave Bioscience AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brave Bioscience AB filed Critical Brave Bioscience AB
Publication of AU2019220368A1 publication Critical patent/AU2019220368A1/en
Application granted granted Critical
Publication of AU2019220368B2 publication Critical patent/AU2019220368B2/en
Priority to AU2024204557A priority Critical patent/AU2024204557A1/en
Assigned to BRAVE BIOSCIENCE AB reassignment BRAVE BIOSCIENCE AB Request for Assignment Assignors: BJÖRKLUND, Tomas, DAVIDSSON, MARCUS
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2019220368A 2018-02-15 2019-02-14 Modified viral capsids Active AU2019220368B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2024204557A AU2024204557A1 (en) 2018-02-15 2024-07-01 Modified Viral Capsids

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18156932 2018-02-15
EP18156932.8 2018-02-15
PCT/EP2019/053610 WO2019158619A1 (en) 2018-02-15 2019-02-14 Modified viral capsids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2024204557A Division AU2024204557A1 (en) 2018-02-15 2024-07-01 Modified Viral Capsids

Publications (2)

Publication Number Publication Date
AU2019220368A1 AU2019220368A1 (en) 2020-10-08
AU2019220368B2 true AU2019220368B2 (en) 2024-06-13

Family

ID=61521290

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2019220368A Active AU2019220368B2 (en) 2018-02-15 2019-02-14 Modified viral capsids
AU2024204557A Pending AU2024204557A1 (en) 2018-02-15 2024-07-01 Modified Viral Capsids

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2024204557A Pending AU2024204557A1 (en) 2018-02-15 2024-07-01 Modified Viral Capsids

Country Status (9)

Country Link
US (2) US20210107947A1 (https=)
EP (1) EP3752521A1 (https=)
JP (2) JP2021514207A (https=)
CN (1) CN112105630A (https=)
AU (2) AU2019220368B2 (https=)
BR (1) BR112020016666A2 (https=)
CA (1) CA3095660A1 (https=)
SG (1) SG11202009854XA (https=)
WO (1) WO2019158619A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023518809A (ja) * 2020-03-20 2023-05-08 ディグニティー ヘルス アデノ随伴ウイルスの改変方法及び分離方法
CN116390773A (zh) 2020-08-06 2023-07-04 应用医学研究基金会 用于通过基因疗法治疗诸如阿尔茨海默病的Tau蛋白病的病毒颗粒
KR20240095539A (ko) 2021-10-08 2024-06-25 디노 테라퓨틱스, 인코포레이티드 캡시드 변이체 및 이의 사용 방법
CN115894659B (zh) * 2022-10-19 2023-11-10 上海优宁维生物科技股份有限公司 微管相关蛋白Tau抗原及其制备方法和应用
WO2024191778A1 (en) 2023-03-10 2024-09-19 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
AU2024332181A1 (en) 2023-08-31 2026-02-12 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2025082618A1 (en) 2023-10-20 2025-04-24 Fuse Vectors Aps In vitro parvovirus capsid manufacturing
TW202545971A (zh) 2024-02-08 2025-12-01 美商戴諾治療公司 殼體多肽及其使用方法
WO2026064442A2 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6368901A (en) * 2000-05-31 2001-12-11 Univ Saskatchewan Modified bovine adenovirus having altered tropism
SI1496944T1 (sl) * 2002-05-01 2009-02-28 Univ Florida Izboljšani sistemi ekspresije RAAV za genetsko modifikacijo specifičnih kapsidnih proteinov
WO2015048534A1 (en) * 2013-09-26 2015-04-02 University Of Florida Research Foundation, Inc. Synthetic combinatorial aav capsid library for targeted gene therapy
WO2015117010A2 (en) * 2014-01-31 2015-08-06 Temple University Of The Commonwealth System Of Higher Education Bag3 as a target for therapy of heart failure
EP3200830B1 (en) * 2014-10-03 2020-09-09 University of Massachusetts High efficiency library-identified aav vectors
AU2016219789B2 (en) * 2015-02-20 2021-03-25 Fondazione Telethon Methods and compositions for treating genetic eye diseases
US11866462B2 (en) * 2016-05-04 2024-01-09 Oregon Health & Science University Recombinant adeno-associated viral vectors
AU2017302013B2 (en) * 2016-07-29 2022-05-26 The Regents Of The University Of California Adeno-associated virus virions with variant capsid and methods of use thereof
AU2017341849B2 (en) * 2016-10-13 2024-03-21 University Of Massachusetts AAV capsid designs
WO2018119330A2 (en) * 2016-12-22 2018-06-28 Oregon Health & Science University Adeno associated viral vectors
EP3585883A4 (en) * 2017-02-21 2021-04-14 University of Florida Research Foundation, Incorporated MODIFIED AAV CAPSID PROTEINS AND USES THEREOF
CA3053154A1 (en) * 2017-06-30 2019-01-03 The Regents Of The University Of California Adeno-associated virus virions with variant capsids and methods of use thereof

Also Published As

Publication number Publication date
BR112020016666A2 (pt) 2020-12-15
US20210107947A1 (en) 2021-04-15
JP2021514207A (ja) 2021-06-10
CA3095660A1 (en) 2019-08-22
SG11202009854XA (en) 2020-11-27
WO2019158619A1 (en) 2019-08-22
AU2019220368A1 (en) 2020-10-08
AU2024204557A1 (en) 2024-07-25
EP3752521A1 (en) 2020-12-23
CN112105630A (zh) 2020-12-18
US20250051396A1 (en) 2025-02-13
JP2024050766A (ja) 2024-04-10

Similar Documents

Publication Publication Date Title
AU2019220368B2 (en) Modified viral capsids
RU2727672C2 (ru) Нацеливающие пептиды для направленной доставки аденоассоциированных вирусов (aav)
CN112004820B (zh) 具有增强的人胰腺向性的新型重组腺相关病毒衣壳
JP2019195338A (ja) 標的遺伝子治療のための合成コンビナトリアルａａｖカプシドライブラリー
BR112019019015A2 (pt) vírions de vírus adeno-associado com capsídeos variantes e seus métodos de uso
US20220372512A1 (en) Methods and aav vectors for in vivo transduction
CN111718418B (zh) 一种增强基因编辑的融合蛋白及其应用
CN113025633A (zh) 编码人nadh脱氢酶亚单位1蛋白的核酸及其应用
JP2026509271A (ja) カプシドポリペプチドおよびその使用方法
CN111718420A (zh) 一种用于基因治疗的融合蛋白及其应用
WO2023184107A1 (en) Crispr-cas13 system for treating mecp2-associated diseases
Davidsson et al. Barcoded Rational AAV Vector Evolution enables systematic in vivo mapping of peptide binding motifs
EP4729620A1 (en) Gene therapy vector for treating parkinson's disease and use thereof
WO2025024826A1 (en) Adeno-associated virus with engineered capsid
JP2024517957A (ja) ベクター系
US12509490B2 (en) AAV capsids for targeting nervous system and uses thereof
Goertsen Expanding adeno-associated viral capsid engineering to multiple variable regions for diversified tropism
EP4410987A1 (en) An aav9 capsid variant for targeted gene transfer
CN117836420A (zh) 重组tert编码病毒基因组和运载体
HK40109651A (zh) 重组tert编码病毒基因组和运载体
WO2025051747A1 (en) Viral vector for fibroblast transfection
WO2025160405A1 (en) Compositions and methods for generation and secretion of aav particles
WO2020187272A1 (zh) 一种用于基因治疗的融合蛋白及其应用
Herrmann Dissection and optimization of Adeno-associated virus (AAV) DNA family shuffling technology: The journey is the reward

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: BRAVE BIOSCIENCE AB

Free format text: FORMER OWNER(S): BJOERKLUND, TOMAS; DAVIDSSON, MARCUS